Latest News

15.05.2013

Results of Comparative Study between Epigenomics Epi proColon® and FIT to be Presented at Digestive Disease Week

PDF 84 KB

08.05.2013

Epigenomics AG Announces Q1 2013 Financial Results and Reports on Operational Highlights

PDF 112 KB

03.04.2013

Epigenomics AG: Dr. Uwe Staub Appointed to the Executive Board

PDF 36 KB

21.03.2013

Epigenomics AG Reports Results for the Financial Year Ended 31 December 2012

PDF 249 KB

07.03.2013

Epigenomics signs licensing agreement with BioChain for Septin9 in China

PDF 70 KB

21.02.2013

Epigenomics receives notification of priority review status and acceptance for filing by FDA of PMA application for Epi proColon®

PDF 66 KB

29.01.2013

Predictive Biosciences launches prostate cancer test based on Epigenomics’ DNA methylation marker

07.01.2013

Epigenomics AG submits the fourth module and completes its PMA submission to the FDA for Epi proColon®

PDF 142 KB